申请人:GENENTECH, INC.
公开号:US20140227299A1
公开(公告)日:2014-08-14
The present invention relates to antibody-drug conjugate compounds of Formula I:
Ab-(L-D)
p
I
where one or more nemorubicin metabolite or analog drug moieties (D) are covalently attached by a linker (L) to an antibody (Ab) which binds to one or more tumor-associated antigens or cell-surface receptors. These compounds may be useful in methods of diagnosis or treatment of cancer, and other diseases and disorders.